MedTrace Logo

HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia

NCT03663920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4336

Last updated 2023-11-13

No results posted yet for this study

Summary

INA-PROACTIVE is a multicenter, prospective, observational cohort study of HIV positive antiretroviral-naïve and treatment-experienced individuals. No investigational treatment or intervention will be used by this study. All participants will be managed according to the Indonesian HIV/AIDS Treatment Guideline and/or the Standard of Care (SoC) in local clinical setting, with the addition of rapid HIV viral load, CD4 cell count and syphilis testing.

Conditions

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Ina-Respond

    lead OTHER

Principal Investigators

  • Prof. Dr. dr. Tuti Parwati Merati, Sp.PD.KPTI · Faculty of Medicine Udayana University-Sanglah Hospital, Denpasar

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-09
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03663920 on ClinicalTrials.gov